Partner/Owner since 1981
Representative before the EPO

Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Peter Riedl has worked on the following 1 EPO patent applications which have been published in the last five years:

EP10796540

HEPATITIS C VIRUS INHIBITORS

IPC classification:
C07D 403/14, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Peter Riedl, Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED

Please Sign in to use this feature